Caricamento...
Focus on α4β2* and α6β2* nAChRs for Parkinson’s Disease Therapeutics
L-dopa is one of the best treatments for the motor symptoms of Parkinson’s disease. However, its use is limited by the fact that it provides only symptomatic relief and chronic therapy leads to dyskinesias. There is therefore a continual search for novel therapeutic approaches. Nicotine, a drug that...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3076673/ https://ncbi.nlm.nih.gov/pubmed/21499569 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|